BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 18754812)

  • 41. "Alternatively activated" dendritic cells preferentially secrete IL-10, expand Foxp3+CD4+ T cells, and induce long-term organ allograft survival in combination with CTLA4-Ig.
    Lan YY; Wang Z; Raimondi G; Wu W; Colvin BL; de Creus A; Thomson AW
    J Immunol; 2006 Nov; 177(9):5868-77. PubMed ID: 17056511
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
    Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
    Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oral tolerance and OVA-induced tolerogenic dendritic cells reduce the severity of collagen/ovalbumin-induced arthritis in mice.
    Thomé R; Fernandes LG; Mineiro MF; Simioni PU; Joazeiro PP; Tamashiro WM
    Cell Immunol; 2012 Nov; 280(1):113-23. PubMed ID: 23298866
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Apoptotic dendritic cells induce tolerance in mice through suppression of dendritic cell maturation and induction of antigen-specific regulatory T cells.
    Kushwah R; Oliver JR; Zhang J; Siminovitch KA; Hu J
    J Immunol; 2009 Dec; 183(11):7104-18. PubMed ID: 19917707
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tolerogenic Dendritic Cells Generated by BAFF Silencing Ameliorate Collagen-Induced Arthritis by Modulating the Th17/Regulatory T Cell Balance.
    Zhao Y; Sun X; Yang X; Zhang B; Li S; Han P; Zhang B; Wang X; Li S; Chang Y; Wei W
    J Immunol; 2020 Feb; 204(3):518-530. PubMed ID: 31843958
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CTLA-4 expressed by FOXP3
    Klocke K; Holmdahl R; Wing K
    Immunology; 2017 Sep; 152(1):125-137. PubMed ID: 28497863
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Selective expansion of foxp3-positive regulatory T cells and immunosuppression by suppressors of cytokine signaling 3-deficient dendritic cells.
    Matsumura Y; Kobayashi T; Ichiyama K; Yoshida R; Hashimoto M; Takimoto T; Tanaka K; Chinen T; Shichita T; Wyss-Coray T; Sato K; Yoshimura A
    J Immunol; 2007 Aug; 179(4):2170-9. PubMed ID: 17675476
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The suppression effect of dendritic cells maturation by adipose-derived stem cells through TGF-β1 related pathway.
    Wang YC; Chen RF; Brandacher G; Lee WPA; Kuo YR
    Exp Cell Res; 2018 Sep; 370(2):708-717. PubMed ID: 30053444
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human dendritic cells produce TGF-beta 1 under the influence of lung carcinoma cells and prime the differentiation of CD4+CD25+Foxp3+ regulatory T cells.
    Dumitriu IE; Dunbar DR; Howie SE; Sethi T; Gregory CD
    J Immunol; 2009 Mar; 182(5):2795-807. PubMed ID: 19234174
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rosiglitazone-mediated dendritic cells ameliorate collagen-induced arthritis in mice.
    Byun SH; Lee JH; Jung NC; Choi HJ; Song JY; Seo HG; Choi J; Jung SY; Kang S; Choi YS; Chung JH; Lim DS
    Biochem Pharmacol; 2016 Sep; 115():85-93. PubMed ID: 27208887
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The influence of HLA-DR4 (0401) on the immune response to type II collagen and the development of collagen induced arthritis in mice.
    Wang D; Hill JA; Cairns E; Bell DA
    J Autoimmun; 2002 Mar; 18(2):95-103. PubMed ID: 11908942
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of human allergic T-helper type 2 immune responses by induced regulatory T cells requires the combination of interleukin-10-treated dendritic cells and transforming growth factor-beta for their induction.
    Bellinghausen I; König B; Böttcher I; Knop J; Saloga J
    Clin Exp Allergy; 2006 Dec; 36(12):1546-55. PubMed ID: 17177678
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interleukin-23 promotes Th17 differentiation by inhibiting T-bet and FoxP3 and is required for elevation of interleukin-22, but not interleukin-21, in autoimmune experimental arthritis.
    Mus AM; Cornelissen F; Asmawidjaja PS; van Hamburg JP; Boon L; Hendriks RW; Lubberts E
    Arthritis Rheum; 2010 Apr; 62(4):1043-50. PubMed ID: 20131264
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tolerogenic dendritic cells induced the enrichment of CD4
    Jia L; Lu J; Zhou Y; Tao Y; Xu H; Zheng W; Zhao J; Liang G; Xu L
    Clin Immunol; 2018 Dec; 197():118-129. PubMed ID: 30248398
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Selective depletion of CD11c
    Wang L; Li Z; Ciric B; Safavi F; Zhang GX; Rostami A
    Eur J Immunol; 2016 Oct; 46(10):2454-2466. PubMed ID: 27338697
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The mechanisms of hydroxychloroquine in rheumatoid arthritis treatment: Inhibition of dendritic cell functions via Toll like receptor 9 signaling.
    Han J; Li X; Luo X; He J; Huang X; Zhou Q; Han Y; Jie H; Zhuang J; Li Y; Yang F; Zhai Z; Wu S; He Y; Yang B; Sun E
    Biomed Pharmacother; 2020 Dec; 132():110848. PubMed ID: 33049581
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of polysaccharide fractions isolated from Caltha palustris L. on the cellular immune response in collagen-induced arthritis (CIA) in mice. A comparison with methotrexate.
    Suszko A; Obmińska-Mrukowicz B
    J Ethnopharmacol; 2013 Jan; 145(1):109-17. PubMed ID: 23123796
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intravenous tolerization with type II collagen induces interleukin-4-and interleukin-10-producing CD4+ T cells.
    Gumanovskaya ML; Myers LK; Rosloniec EF; Stuart JM; Kang AH
    Immunology; 1999 Jul; 97(3):466-73. PubMed ID: 10447769
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vaccination without autoantigen protects against collagen II-induced arthritis via immune deviation and regulatory T cells.
    Kochetkova I; Trunkle T; Callis G; Pascual DW
    J Immunol; 2008 Aug; 181(4):2741-52. PubMed ID: 18684965
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Induction of Interleukin-10 Producing Dendritic Cells As a Tool to Suppress Allergen-Specific T Helper 2 Responses.
    Schülke S
    Front Immunol; 2018; 9():455. PubMed ID: 29616018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.